Both an oral formulation and a high-dose injectable version of Novo Nordisk's Wegovy (semaglutide) are edging closer to the European market, after a committee at the European Medicines Agency (EMA) ...
The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...
Novo Nordisk (NVO) announced on Wednesday that the European Commission granted marketing authorization for its Wegovy pill and a single-dose pen containing a higher-dose version of Wegovy injectable.
The Wegovy weight loss pill is the UK's first GLP-1 weight-loss tablet and offers patients a new alternative to weekly weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results